Abstract

The pharmaceutical industry is experiencing a significant digital transformation driven by the need to enhance efficiency, product quality, and regulatory compliance in an increasingly complex environment. This study examines the impact of digital transformation on data integrity and quality management systems (QMS) in the pharmaceutical sector. Through a comprehensive systematic literature review, the research explores the underlying reasons for digital transformation, identifies key challenges in implementing digitally enabled QMS, and evaluates the benefits of regulatory compliance through digital technologies. The study also investigates future trends and opportunities in the digital transformation of pharmaceutical QMS, including adopting blockchain, the Internet of Things (IoT), artificial intelligence, and machine learning. Findings indicate that while digital transformation offers substantial benefits in improving data integrity, streamlining processes, and enhancing regulatory compliance, pharmaceutical companies face significant challenges in implementation, including legacy system integration, data standardization, and organizational resistance to change. The article highlights the importance of a strategic, comprehensive, and collaborative approach to digital transformation, encompassing technology, people, processes, and partnerships.

This work is licensed under a Creative Commons Attribution 4.0 License.